(firstQuint)Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium.

 1.

 Impending recurrent pterygium 2.

 Anti-VEGF therapy - Bevacizumab - Subconjunctival injection - Suppress neovascularization.

 Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium@highlight

Hypothesis: Subconjunctival bevacizumab injection may potentially suppress neovascularization in pterygium, preventing or retarding the progression of recurrence.

